Reputation is very subjective. Did these Mako arti
Post# of 72440
(Total Views: 191)
Posted On: 01/18/2017 8:13:39 AM
Re: thefamilyman #30572
Reputation is very subjective. Did these Mako articles damage CTIX's reputation in the eyes of Pfizer, Celgene and other BPs? CTIX doesn't sell products and convincing a judge that BPs put much weight in SA articles is tough.
It varies from venue to venue but it appears to be a moot point. I still await a piece of case law which sets a stronger precedent than NNVC vs SA. Similar company, same writer (we think), same formula and same Seeking Alpha just two years ago. I believe that even if the SEC asked for a subpoena the presiding judge would review that case and have to throw it out.
It varies from venue to venue but it appears to be a moot point. I still await a piece of case law which sets a stronger precedent than NNVC vs SA. Similar company, same writer (we think), same formula and same Seeking Alpha just two years ago. I believe that even if the SEC asked for a subpoena the presiding judge would review that case and have to throw it out.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All content of my posts is my opinion and speculation. Do not treat anything I say as fact or actionable investment advice. I participate to challenge my investment thesis from any angle possible. Please do your own due diligence.
Current Positions:
Long CTIX.
Current Positions:
Long CTIX.
Scroll down for more posts ▼